Didanosine: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Didanosine}} | |||
{{CMG}} | |||
==Overview== | |||
==Category== | |||
Antiretroviral drug | |||
==US Brand Names== | |||
==FDA Package Insert== | |||
''' [[Didanosine description|Description]]''' | |||
'''| [[Didanosine clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Didanosine microbiology|Microbiology]]''' | |||
'''| [[Didanosine indications and usage|Indications and Usage]]''' | |||
'''| [[Didanosine contraindications|Contraindications]]''' | |||
'''| [[Didanosine warnings and precautions|Warnings and Precautions]]''' | |||
'''| [[Didanosine adverse reactions|Adverse Reactions]]''' | |||
'''| [[Didanosine overdosage|Overdosage]]''' | |||
'''| [[Didanosine clinical studies|Clinical Studies]]''' | |||
'''| [[Didanosine dosage and administration|Dosage and Administration]]''' | |||
'''| [[Didanosine compatibility reconstitution and stability|Compatibility, Reconstitution, and Stability]]''' | |||
'''| [[Didanosine directions for use|Directions For Use]]''' | |||
'''| [[Didanosine how supplied|How Supplied]]''' | |||
'''| [[Didanosine labels and packages|Labels and Packages]]''' | |||
==Mechanism of Action== | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Antibiotics]] | |||
[[Category:Wikinfect]] | |||
Revision as of 05:20, 1 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Category
Antiretroviral drug
US Brand Names
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility, Reconstitution, and Stability | Directions For Use | How Supplied | Labels and Packages